Investigation Launched into Myriad Genetics: Impact of UnitedHealth Coverage Changes
- Overview Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of Myriad Genetics, Inc.
- Details of Investigation On October 31, 2024, UnitedHealth Group announced it would stop covering GeneSight, a Myriad genetic test that determines suitable mental health medications.
- Next Steps for Investors Investors with information related to this situation or who purchased Myriad securities are encouraged to visit bgandg.com/MYGN to assist the investigation.
Investigation of Myriad Genetics, Inc.
Overview
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of Myriad Genetics, Inc. (NASDAQ: MYGN). Those who purchased Myriad securities can find more information and assist in this investigation at bgandg.com/MYGN.
Details of Investigation
On October 31, 2024, UnitedHealth Group announced it would stop covering GeneSight, a Myriad genetic test that determines suitable mental health medications. This change will take effect on January 1, 2025. UnitedHealth’s documentation stated that behavioral health tests like GeneSight are “unproven” and “not medically necessary.” Following this news, Myriad’s stock price dropped significantly on November 1, 2024.
Next Steps for Investors
Investors with information related to this situation or who purchased Myriad securities are encouraged to visit bgandg.com/MYGN to assist the investigation. They can also reach out to Peretz Bronstein or Nathan Miller at 332-239-2660.
No Cost for Assistance
The firm operates on a contingency fee basis, meaning they will only collect fees if the court awards compensation for the investors.
Why Choose Bronstein, Gewirtz & Grossman?
The firm is known for representing investors in securities fraud cases. They have recovered hundreds of millions of dollars for clients across the country.
Contact Information
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]
Source
Bronstein, Gewirtz & Grossman, LLC